Anzeige
Mehr »
Samstag, 26.07.2025 - Börsentäglich über 12.000 News
Richtig investiert verwandelt der Goldpreis jeden Euro in glänzendes Vermögen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CMH3 | ISIN: SE0015661152 | Ticker-Symbol: 7ZT
Frankfurt
25.07.25 | 21:45
0,434 Euro
+2,97 % +0,013
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
HAMLET BIOPHARMA AB Chart 1 Jahr
5-Tage-Chart
HAMLET BIOPHARMA AB 5-Tage-Chart

Aktuelle News zur HAMLET BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.07.HAMLET BIOPHARMA AB: Hamlet BioPharma proposes a directed new share issue to finance continued development and commercialization based on three positive Phase II studies1
04.07.XFRA NEW INSTRUMENTS AVAILABLE ON 04.07.2025547The following instruments on XETRA do have their first trading 04.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 04.07.2025 Aktien 1 SGXE14976547 Meituan SDR 2 SGXE81412038...
► Artikel lesen
25.06.Hamlet BioPharma AB (publ): Hamlet BioPharma Holds Successful In Person Meeting with US FDA296LUND, Sweden, June 25, 2025 /PRNewswire/ -- Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections...
► Artikel lesen
17.06.HAMLET BIOPHARMA AB: Hamlet BioPharma announces progress in Tuberculosis therapy1
17.06.HAMLET BIOPHARMA AB: Hamlet BioPharma invites to investor meeting on the 18th of June2
22.05.HAMLET BIOPHARMA AB: Q3 INTERIM REPORT JANUARY - MARCH 20252
19.05.HAMLET BIOPHARMA AB: Scientific Breakthrough in Alpha1H's Mechanism of Action2
HAMLET BIOPHARMA Aktie jetzt für 0€ handeln
22.04.HAMLET BIOPHARMA AB: Hamlet BioPharma invites to investor meeting on the 23rd of April2
08.04.HAMLET BIOPHARMA AB: New discoveries in infection biology, highlighting the rich potential of non-antibiotic treatments of infections2
08.04.HAMLET BIOPHARMA AB: New scientific advances for Alpha1H highlight the unique discovery pipeline and drug development potential for the treatment of bladder cancer1
07.04.HAMLET BIOPHARMA AB: New granted patents added to Hamlet BioPharma's extensive patent portfolio in cancer and infection2
07.04.HAMLET BIOPHARMA AB: Strong Alpha1H treatment effects confirmed in patients with bladder cancer, in final analysis. Clinical study report is being completed for submission to the FDA1
20.02.HAMLET BIOPHARMA AB: The board of Hamlet BioPharma proposes licensing agreement with Linnane Pharma, which creates conditions for an effective commercialization of Bamlet and positive value for both companies2
19.02.HAMLET BIOPHARMA AB: Elisabeth Parker appointed as Business development expert in Hamlet BioPharma and joins the team on March 3rd1
18.02.HAMLET BIOPHARMA AB: Catharina Svanborg appointed as CEO and assumes the position immediately, board member Magnus Nylén acting Chairman1
13.02.HAMLET BIOPHARMA AB: Q2 Interim Report October 2024 - December 20242
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1